肝疾患診断薬の世界市場インサイト、2029年までの予測Global Liver Disease Diagnostics Market Insights, Forecast to 2029 肝疾患診断薬の世界市場は、2023年の133億6,164万米ドルから2029年には201億2,098万米ドルに成長し、予測期間中の年間平均成長率(CAGR)は7.05%と予測されている。 2022年の北米肝疾患診断薬市場規模は50億192... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー肝疾患診断薬の世界市場は、2023年の133億6,164万米ドルから2029年には201億2,098万米ドルに成長し、予測期間中の年間平均成長率(CAGR)は7.05%と予測されている。2022年の北米肝疾患診断薬市場規模は50億1920万米ドル、アジア太平洋地域は30億3697万米ドル、ヨーロッパ肝疾患診断薬は36億9005万米ドルである。2022年における北米の割合は40.95%、APACと欧州はそれぞれ24.78%と30.11%であり、APACの割合は2029年には28.57%に達すると予測され、分析期間を通じて年平均成長率は8.99%である。APACでは中国、日本、韓国、インドが注目すべき市場である。欧州の肝疾患診断薬ランドスケープに関しては、ドイツは2029年までに12億9,290万米ドルに達すると予測され、2023-2029年のCAGRは6.06%であった。 肝疾患診断薬の世界的な主要企業には、ロシュ、アボット、サーモフィッシャーサイエンティフィック、シーメンス・ヘルスイニアーズ、GEヘルスケア、キヤノンメディカルシステムズ、ラボコープ、BD、フィリップスヘルスケアなどがあり、ランドックスラボラトリーズは肝疾患診断薬の世界市場における主要メーカーである。2022年の市場シェアは、売上高上位10社で39.41%を占めた。 レポートの内容 肝疾患診断薬の世界市場規模を概観します。2018年~2022年の過去の市場収益データ、2023年の推定値、2029年までのCAGR予測による世界市場動向の分析。 肝疾患診断薬の主要生産者を調査し、主要地域と国の収益も掲載しています。肝疾患診断薬の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国に焦点を当てたハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。 本レポートでは、2018年から2023年までのデータで、肝疾患診断薬の収益、市場シェア、主要企業の業界ランキングに焦点を当てています。世界の肝疾患診断薬市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。 本レポートでは、2018年から2029年までのタイプ別、用途別のセグメントデータ、収益、成長率を分析しています。肝疾患診断薬の収益、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。 アボット、ロシュ、サーモフィッシャーサイエンティフィック、ランドックス診断センター、ボストン・サイエンティフィック・コーポレーション、ラボコープ、富士フイルム、堀場製作所、シーメンス・ヘルティニアーズなど、世界の主要企業の詳細な企業プロフィール。 会社別 アボット ロシュ サーモフィッシャーサイエンティフィック ランドックス・ラボラトリーズ ボストン・サイエンティフィック ラボコープ 富士フイルム シーメンス・ヘルスイニアーズ BD クックメディカル GEヘルスケア フィリップスヘルスケア キヤノンメディカルシステムズ キアゲン タイプ別セグメント 画像検査 血液検査 生検 アプリケーション別 病院および診療所 診断センター その他 地域別 北米 米国 カナダ メキシコ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア ヨーロッパ ドイツ フランス 英国 イタリア スイス その他のヨーロッパ ラテンアメリカ ブラジル アルゼンチン その他のラテンアメリカ 中東・アフリカ サウジアラビア アラブ首長国連邦 イスラエル その他のMEA 目次1 Report Overview 11.1 Study Scope 1 1.2 Market Analysis by Type 1 1.2.1 Global Liver Disease Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1 1.2.2 Imaging Tests 3 1.2.3 Blood Tests 4 1.2.4 Biopsy 5 1.3 Market by Application 6 1.3.1 Global Liver Disease Diagnostics Market Share by Application: 2018 VS 2022 VS 2029 6 1.3.2 Hospitals and Clinics 8 1.3.3 Diagnostic Centers 9 1.3.4 Others 9 1.4 Assumptions and Limitations 10 1.5 Study Objectives 11 1.6 Years Considered 11 2 Global Growth Trends 13 2.1 Global Liver Disease Diagnostics Market Perspective (2018-2029) 13 2.2 Global Liver Disease Diagnostics Growth Trends by Region 14 2.2.1 Global Liver Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2029 15 2.2.2 Liver Disease Diagnostics Historic Market Size by Region (2018-2023) 16 2.2.3 Liver Disease Diagnostics Forecasted Market Size by Region (2024-2029) 17 2.3 Liver Disease Diagnostics Market Dynamics 18 2.3.1 Liver Disease Diagnostics Industry Trends 18 2.3.2 Liver Disease Diagnostics Market Drivers 19 2.3.3 Liver Disease Diagnostics Market Challenges 20 2.3.4 Liver Disease Diagnostics Market Restraints 20 3 Competition Landscape by Key Players 21 3.1 Global Revenue Liver Disease Diagnostics by Players 21 3.1.1 Global Liver Disease Diagnostics Revenue by Players (2018-2023) 21 3.1.2 Global Liver Disease Diagnostics Revenue Market Share by Players (2018-2023) 22 3.2 Global Liver Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 23 3.3 Global Key Players of Liver Disease Diagnostics, Ranking by Revenue 24 3.4 Global Liver Disease Diagnostics Market Concentration Ratio 25 3.4.1 Global Liver Disease Diagnostics Market Concentration Ratio (CR5 and HHI) 25 3.4.2 Global Top 10 and Top 5 Companies by Liver Disease Diagnostics Revenue in 2022 26 3.5 Global Key Players of Liver Disease Diagnostics Head office and Manufacturing Sites 27 3.6 Global Key Players of Liver Disease Diagnostics Product 28 3.7 Global Key Players of Liver Disease Diagnostics, Founded Date 28 3.8 Mergers & Acquisitions, Expansion Plans 29 4 Liver Disease Diagnostics Breakdown Data by Type 32 4.1 Global Liver Disease Diagnostics Historic Market Size by Type (2018-2023) 32 4.2 Global Liver Disease Diagnostics Forecasted Market Size by Type (2024-2029) 33 5 Liver Disease Diagnostics Breakdown Data by Application 34 5.1 Global Liver Disease Diagnostics Historic Market Size by Application (2018-2023) 34 5.2 Global Liver Disease Diagnostics Forecasted Market Size by Application (2024-2029) 35 6 North America 36 6.1 North America Liver Disease Diagnostics Market Size (2018-2029) 36 6.2 North America Liver Disease Diagnostics Market Size by Type 36 6.2.1 North America Liver Disease Diagnostics Market Size by Type (2018-2023) 36 6.2.2 North America Liver Disease Diagnostics Market Size by Type (2024-2029) 37 6.2.3 North America Liver Disease Diagnostics Market Share by Type (2018-2029) 37 6.3 North America Liver Disease Diagnostics Market Size by Application 38 6.3.1 North America Liver Disease Diagnostics Market Size by Application (2018-2023) 38 6.3.2 North America Liver Disease Diagnostics Market Size by Application (2024-2029) 38 6.3.3 North America Liver Disease Diagnostics Market Share by Application (2018-2029) 39 6.4 North America Liver Disease Diagnostics Market Size by Country 39 6.4.1 North America Liver Disease Diagnostics Market Size by Country (2018-2023) 39 6.4.2 North America Liver Disease Diagnostics Market Share by Country (2024-2029) 40 6.4.3 United States 41 6.4.4 Canada 41 6.4.5 Mexico 42 7 Europe 43 7.1 Europe Liver Disease Diagnostics Market Size (2018-2029) 43 7.2 Europe Liver Disease Diagnostics Market Size by Type 43 7.2.1 Europe Liver Disease Diagnostics Market Size by Type (2018-2023) 43 7.2.2 Europe Liver Disease Diagnostics Market Size by Type (2024-2029) 44 7.2.3 Europe Liver Disease Diagnostics Market Share by Type (2018-2029) 44 7.3 Europe Liver Disease Diagnostics Market Size by Application 45 7.3.1 Europe Liver Disease Diagnostics Market Size by Application (2018-2023) 45 7.3.2 Europe Liver Disease Diagnostics Market Size by Application (2024-2029) 45 7.3.3 Europe Liver Disease Diagnostics Market Share by Application (2018-2029) 46 7.4 Europe Liver Disease Diagnostics Market Size by Country 46 7.4.1 Europe Liver Disease Diagnostics Market Size by Country (2018-2023) 46 7.4.2 Europe Liver Disease Diagnostics Market Size by Country (2024-2029) 47 7.4.3 Germany 48 7.4.4 France 48 7.4.5 U.K. 49 7.4.6 Italy 49 7.4.7 Switzerland 50 8 Asia Pacific 51 8.1 Asia Pacific Liver Disease Diagnostics Market Size (2018-2029) 51 8.2 Asia Pacific Liver Disease Diagnostics Market Size by Type 51 8.2.1 Asia Pacific Liver Disease Diagnostics Market Size by Type (2018-2023) 51 8.2.2 Asia Pacific Liver Disease Diagnostics Market Size by Type (2024-2029) 52 8.2.3 Asia Pacific Liver Disease Diagnostics Market Share by Type (2018-2029) 52 8.3 Asia Pacific Liver Disease Diagnostics Market Size by Application 53 8.3.1 Asia Pacific Liver Disease Diagnostics Market Size by Application (2018-2023) 53 8.3.2 Asia Pacific Liver Disease Diagnostics Market Size by Application (2024-2029) 53 8.3.3 Asia Pacific Liver Disease Diagnostics Market Share by Application (2018-2029) 54 8.4 Asia Pacific Liver Disease Diagnostics Market Size by Region 54 8.4.1 Asia Pacific Liver Disease Diagnostics Market Size by Region (2018-2023) 54 8.4.2 Asia Pacific Liver Disease Diagnostics Market Size by Region (2024-2029) 55 8.4.3 China 56 8.4.4 Japan 56 8.4.5 South Korea 57 8.4.6 Southeast Asia 58 8.4.7 India 58 8.4.8 Australia 59 9 Latin America 60 9.1 Latin America Liver Disease Diagnostics Market Size (2018-2029) 60 9.2 Latin America Liver Disease Diagnostics Market Size by Type 60 9.2.1 Latin America Liver Disease Diagnostics Market Size by Type (2018-2023) 60 9.2.2 Latin America Liver Disease Diagnostics Market Size by Type (2024-2029) 61 9.2.3 Latin America Liver Disease Diagnostics Market Share by Type (2018-2029) 61 9.3 Latin America Liver Disease Diagnostics Market Size by Application 62 9.3.1 Latin America Liver Disease Diagnostics Market Size by Application (2018-2023) 62 9.3.2 Latin America Liver Disease Diagnostics Market Size by Application (2024-2029) 62 9.3.3 Latin America Liver Disease Diagnostics Market Share by Application (2018-2029) 63 9.4 Latin America Liver Disease Diagnostics Market Size by Country 63 9.4.1 Latin America Liver Disease Diagnostics Market Size by Country (2018-2023) 63 9.4.2 Latin America Liver Disease Diagnostics Market Size by Country (2024-2029) 64 9.4.3 Brazil 65 9.4.4 Argentina 65 10 Middle East & Africa 66 10.1 Middle East & Africa Liver Disease Diagnostics Market Size (2018-2029) 66 10.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type 66 10.2.1 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2018-2023) 66 10.2.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2024-2029) 67 10.2.3 Middle East & Africa Liver Disease Diagnostics Market Share by Type (2018-2029) 68 10.3 Middle East & Africa Liver Disease Diagnostics Market Size by Application 68 10.3.1 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2018-2023) 68 10.3.2 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2024-2029) 69 10.3.3 Middle East & Africa Liver Disease Diagnostics Market Share by Application (2018-2029) 69 10.4 Middle East & Africa Liver Disease Diagnostics Market Size by Country 70 10.4.1 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2018-2023) 70 10.4.2 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2024-2029) 70 10.4.3 Saudi Arabia 71 10.4.4 UAE 72 10.4.5 Israel 72 11 Key Players Profiles 73 11.1 Abbott 73 11.1.1 Abbott Company Details 73 11.1.2 Abbott Business Overview 73 11.1.3 Abbott Liver Disease Diagnostics Introduction 74 11.1.4 Abbott Revenue in Liver Disease Diagnostics Business (2018-2023) 76 11.1.5 Abbott Recent Development 77 11.2 Roche 77 11.2.1 Roche Company Details 78 11.2.2 Roche Business Overview 78 11.2.3 Roche Liver Disease Diagnostics Introduction 79 11.2.4 Roche Revenue in Liver Disease Diagnostics Business (2018-2023) 80 11.2.5 Roche Recent Development 81 11.3 Thermo Fisher Scientific 81 11.3.1 Thermo Fisher Scientific Company Details 81 11.3.2 Thermo Fisher Scientific Business Overview 82 11.3.3 Thermo Fisher Scientific Liver Disease Diagnostics Introduction 82 11.3.4 Thermo Fisher Scientific Revenue in Liver Disease Diagnostics Business (2018-2023) 85 11.4 Randox Diagnostic Centers 86 11.4.1 Randox Diagnostic Centers Company Details 86 11.4.2 Randox Diagnostic Centers Business Overview 87 11.4.3 Randox Diagnostic Centers Liver Disease Diagnostics Introduction 87 11.4.4 Randox Diagnostic Centers Revenue in Liver Disease Diagnostics Business (2018-2023) 89 11.4.5 Randox Diagnostic Centers Recent Development 90 11.5 Boston Scientific Corporation 90 11.5.1 Boston Scientific Corporation Company Details 91 11.5.2 Boston Scientific Corporation Business Overview 91 11.5.3 Boston Scientific Corporation Liver Disease Diagnostics Introduction 92 11.5.4 Boston Scientific Corporation Revenue in Liver Disease Diagnostics Business (2018-2023) 94 11.6 LabCorp 94 11.6.1 LabCorp Company Details 95 11.6.2 LabCorp Business Overview 95 11.6.3 LabCorp Liver Disease Diagnostics Introduction 96 11.6.4 LabCorp Revenue in Liver Disease Diagnostics Business (2018-2023) 96 11.6.5 LabCorp Recent Development 97 11.7 Fujifilm Corporation 98 11.7.1 Fujifilm Corporation Company Details 98 11.7.2 Fujifilm Corporation Business Overview 98 11.7.3 Fujifilm Corporation Liver Disease Diagnostics Introduction 99 11.7.4 Fujifilm Corporation Revenue in Liver Disease Diagnostics Business (2018-2023) 100 11.8 Siemens Healthineers 101 11.8.1 Siemens Healthineers Company Details 101 11.8.2 Siemens Healthineers Business Overview 102 11.8.3 Siemens Healthineers Liver Disease Diagnostics Introduction 102 11.8.4 Siemens Healthineers Revenue in Liver Disease Diagnostics Business (2018-2023) 104 11.9 BD 104 11.9.1 BD Company Details 105 11.9.2 BD Business Overview 105 11.9.3 BD Liver Disease Diagnostics Introduction 106 11.9.4 BD Revenue in Liver Disease Diagnostics Business (2018-2023) 106 11.10 Cook Medical 107 11.10.1 Cook Medical Company Details 107 11.10.2 Cook Medical Business Overview 108 11.10.3 Cook Medical Liver Disease Diagnostics Introduction 108 11.10.4 Cook Medical Revenue in Liver Disease Diagnostics Business (2018-2023) 110 11.11 GE Healthcare 110 11.11.1 GE Healthcare Company Details 111 11.11.2 GE Healthcare Business Overview 111 11.11.3 GE Healthcare Liver Disease Diagnostics Introduction 112 11.11.4 GE Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023) 113 11.12 Philips Healthcare 113 11.12.1 Philips Healthcare Company Details 114 11.12.2 Philips Healthcare Business Overview 114 11.12.3 Philips Healthcare Liver Disease Diagnostics Introduction 115 11.12.4 Philips Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023) 115 11.12.5 Philips Healthcare Recent Development 116 11.13 Canon Medical Systems 116 11.13.1 Canon Medical Systems Company Details 117 11.13.2 Canon Medical Systems Business Overview 117 11.13.3 Canon Medical Systems Liver Disease Diagnostics Introduction 117 11.13.4 Canon Medical Systems Revenue in Liver Disease Diagnostics Business (2018-2023) 118 11.13.5 Canon Medical Systems Recent Development 119 11.14 Qiagen 119 11.14.1 Qiagen Company Details 120 11.14.2 Qiagen Business Overview 120 11.14.3 Qiagen Liver Disease Diagnostics Introduction 121 11.14.4 Qiagen Revenue in Liver Disease Diagnostics Business (2018-2023) 122 12 Analyst's Viewpoints/Conclusions 123 13 Appendix 125 13.1 Research Methodology 125 13.1.1 Methodology/Research Approach 125 13.1.2 Data Source 128 13.2 Author Details 131 13.3 Disclaimer 133
SummaryThe global Liver Disease Diagnostics market is projected to grow from US$ 13,361.64 million in 2023 to US$ 20,102.98 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.05% during the forecast period. Table of Contents1 Report Overview 11.1 Study Scope 1 1.2 Market Analysis by Type 1 1.2.1 Global Liver Disease Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1 1.2.2 Imaging Tests 3 1.2.3 Blood Tests 4 1.2.4 Biopsy 5 1.3 Market by Application 6 1.3.1 Global Liver Disease Diagnostics Market Share by Application: 2018 VS 2022 VS 2029 6 1.3.2 Hospitals and Clinics 8 1.3.3 Diagnostic Centers 9 1.3.4 Others 9 1.4 Assumptions and Limitations 10 1.5 Study Objectives 11 1.6 Years Considered 11 2 Global Growth Trends 13 2.1 Global Liver Disease Diagnostics Market Perspective (2018-2029) 13 2.2 Global Liver Disease Diagnostics Growth Trends by Region 14 2.2.1 Global Liver Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2029 15 2.2.2 Liver Disease Diagnostics Historic Market Size by Region (2018-2023) 16 2.2.3 Liver Disease Diagnostics Forecasted Market Size by Region (2024-2029) 17 2.3 Liver Disease Diagnostics Market Dynamics 18 2.3.1 Liver Disease Diagnostics Industry Trends 18 2.3.2 Liver Disease Diagnostics Market Drivers 19 2.3.3 Liver Disease Diagnostics Market Challenges 20 2.3.4 Liver Disease Diagnostics Market Restraints 20 3 Competition Landscape by Key Players 21 3.1 Global Revenue Liver Disease Diagnostics by Players 21 3.1.1 Global Liver Disease Diagnostics Revenue by Players (2018-2023) 21 3.1.2 Global Liver Disease Diagnostics Revenue Market Share by Players (2018-2023) 22 3.2 Global Liver Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 23 3.3 Global Key Players of Liver Disease Diagnostics, Ranking by Revenue 24 3.4 Global Liver Disease Diagnostics Market Concentration Ratio 25 3.4.1 Global Liver Disease Diagnostics Market Concentration Ratio (CR5 and HHI) 25 3.4.2 Global Top 10 and Top 5 Companies by Liver Disease Diagnostics Revenue in 2022 26 3.5 Global Key Players of Liver Disease Diagnostics Head office and Manufacturing Sites 27 3.6 Global Key Players of Liver Disease Diagnostics Product 28 3.7 Global Key Players of Liver Disease Diagnostics, Founded Date 28 3.8 Mergers & Acquisitions, Expansion Plans 29 4 Liver Disease Diagnostics Breakdown Data by Type 32 4.1 Global Liver Disease Diagnostics Historic Market Size by Type (2018-2023) 32 4.2 Global Liver Disease Diagnostics Forecasted Market Size by Type (2024-2029) 33 5 Liver Disease Diagnostics Breakdown Data by Application 34 5.1 Global Liver Disease Diagnostics Historic Market Size by Application (2018-2023) 34 5.2 Global Liver Disease Diagnostics Forecasted Market Size by Application (2024-2029) 35 6 North America 36 6.1 North America Liver Disease Diagnostics Market Size (2018-2029) 36 6.2 North America Liver Disease Diagnostics Market Size by Type 36 6.2.1 North America Liver Disease Diagnostics Market Size by Type (2018-2023) 36 6.2.2 North America Liver Disease Diagnostics Market Size by Type (2024-2029) 37 6.2.3 North America Liver Disease Diagnostics Market Share by Type (2018-2029) 37 6.3 North America Liver Disease Diagnostics Market Size by Application 38 6.3.1 North America Liver Disease Diagnostics Market Size by Application (2018-2023) 38 6.3.2 North America Liver Disease Diagnostics Market Size by Application (2024-2029) 38 6.3.3 North America Liver Disease Diagnostics Market Share by Application (2018-2029) 39 6.4 North America Liver Disease Diagnostics Market Size by Country 39 6.4.1 North America Liver Disease Diagnostics Market Size by Country (2018-2023) 39 6.4.2 North America Liver Disease Diagnostics Market Share by Country (2024-2029) 40 6.4.3 United States 41 6.4.4 Canada 41 6.4.5 Mexico 42 7 Europe 43 7.1 Europe Liver Disease Diagnostics Market Size (2018-2029) 43 7.2 Europe Liver Disease Diagnostics Market Size by Type 43 7.2.1 Europe Liver Disease Diagnostics Market Size by Type (2018-2023) 43 7.2.2 Europe Liver Disease Diagnostics Market Size by Type (2024-2029) 44 7.2.3 Europe Liver Disease Diagnostics Market Share by Type (2018-2029) 44 7.3 Europe Liver Disease Diagnostics Market Size by Application 45 7.3.1 Europe Liver Disease Diagnostics Market Size by Application (2018-2023) 45 7.3.2 Europe Liver Disease Diagnostics Market Size by Application (2024-2029) 45 7.3.3 Europe Liver Disease Diagnostics Market Share by Application (2018-2029) 46 7.4 Europe Liver Disease Diagnostics Market Size by Country 46 7.4.1 Europe Liver Disease Diagnostics Market Size by Country (2018-2023) 46 7.4.2 Europe Liver Disease Diagnostics Market Size by Country (2024-2029) 47 7.4.3 Germany 48 7.4.4 France 48 7.4.5 U.K. 49 7.4.6 Italy 49 7.4.7 Switzerland 50 8 Asia Pacific 51 8.1 Asia Pacific Liver Disease Diagnostics Market Size (2018-2029) 51 8.2 Asia Pacific Liver Disease Diagnostics Market Size by Type 51 8.2.1 Asia Pacific Liver Disease Diagnostics Market Size by Type (2018-2023) 51 8.2.2 Asia Pacific Liver Disease Diagnostics Market Size by Type (2024-2029) 52 8.2.3 Asia Pacific Liver Disease Diagnostics Market Share by Type (2018-2029) 52 8.3 Asia Pacific Liver Disease Diagnostics Market Size by Application 53 8.3.1 Asia Pacific Liver Disease Diagnostics Market Size by Application (2018-2023) 53 8.3.2 Asia Pacific Liver Disease Diagnostics Market Size by Application (2024-2029) 53 8.3.3 Asia Pacific Liver Disease Diagnostics Market Share by Application (2018-2029) 54 8.4 Asia Pacific Liver Disease Diagnostics Market Size by Region 54 8.4.1 Asia Pacific Liver Disease Diagnostics Market Size by Region (2018-2023) 54 8.4.2 Asia Pacific Liver Disease Diagnostics Market Size by Region (2024-2029) 55 8.4.3 China 56 8.4.4 Japan 56 8.4.5 South Korea 57 8.4.6 Southeast Asia 58 8.4.7 India 58 8.4.8 Australia 59 9 Latin America 60 9.1 Latin America Liver Disease Diagnostics Market Size (2018-2029) 60 9.2 Latin America Liver Disease Diagnostics Market Size by Type 60 9.2.1 Latin America Liver Disease Diagnostics Market Size by Type (2018-2023) 60 9.2.2 Latin America Liver Disease Diagnostics Market Size by Type (2024-2029) 61 9.2.3 Latin America Liver Disease Diagnostics Market Share by Type (2018-2029) 61 9.3 Latin America Liver Disease Diagnostics Market Size by Application 62 9.3.1 Latin America Liver Disease Diagnostics Market Size by Application (2018-2023) 62 9.3.2 Latin America Liver Disease Diagnostics Market Size by Application (2024-2029) 62 9.3.3 Latin America Liver Disease Diagnostics Market Share by Application (2018-2029) 63 9.4 Latin America Liver Disease Diagnostics Market Size by Country 63 9.4.1 Latin America Liver Disease Diagnostics Market Size by Country (2018-2023) 63 9.4.2 Latin America Liver Disease Diagnostics Market Size by Country (2024-2029) 64 9.4.3 Brazil 65 9.4.4 Argentina 65 10 Middle East & Africa 66 10.1 Middle East & Africa Liver Disease Diagnostics Market Size (2018-2029) 66 10.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type 66 10.2.1 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2018-2023) 66 10.2.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2024-2029) 67 10.2.3 Middle East & Africa Liver Disease Diagnostics Market Share by Type (2018-2029) 68 10.3 Middle East & Africa Liver Disease Diagnostics Market Size by Application 68 10.3.1 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2018-2023) 68 10.3.2 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2024-2029) 69 10.3.3 Middle East & Africa Liver Disease Diagnostics Market Share by Application (2018-2029) 69 10.4 Middle East & Africa Liver Disease Diagnostics Market Size by Country 70 10.4.1 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2018-2023) 70 10.4.2 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2024-2029) 70 10.4.3 Saudi Arabia 71 10.4.4 UAE 72 10.4.5 Israel 72 11 Key Players Profiles 73 11.1 Abbott 73 11.1.1 Abbott Company Details 73 11.1.2 Abbott Business Overview 73 11.1.3 Abbott Liver Disease Diagnostics Introduction 74 11.1.4 Abbott Revenue in Liver Disease Diagnostics Business (2018-2023) 76 11.1.5 Abbott Recent Development 77 11.2 Roche 77 11.2.1 Roche Company Details 78 11.2.2 Roche Business Overview 78 11.2.3 Roche Liver Disease Diagnostics Introduction 79 11.2.4 Roche Revenue in Liver Disease Diagnostics Business (2018-2023) 80 11.2.5 Roche Recent Development 81 11.3 Thermo Fisher Scientific 81 11.3.1 Thermo Fisher Scientific Company Details 81 11.3.2 Thermo Fisher Scientific Business Overview 82 11.3.3 Thermo Fisher Scientific Liver Disease Diagnostics Introduction 82 11.3.4 Thermo Fisher Scientific Revenue in Liver Disease Diagnostics Business (2018-2023) 85 11.4 Randox Diagnostic Centers 86 11.4.1 Randox Diagnostic Centers Company Details 86 11.4.2 Randox Diagnostic Centers Business Overview 87 11.4.3 Randox Diagnostic Centers Liver Disease Diagnostics Introduction 87 11.4.4 Randox Diagnostic Centers Revenue in Liver Disease Diagnostics Business (2018-2023) 89 11.4.5 Randox Diagnostic Centers Recent Development 90 11.5 Boston Scientific Corporation 90 11.5.1 Boston Scientific Corporation Company Details 91 11.5.2 Boston Scientific Corporation Business Overview 91 11.5.3 Boston Scientific Corporation Liver Disease Diagnostics Introduction 92 11.5.4 Boston Scientific Corporation Revenue in Liver Disease Diagnostics Business (2018-2023) 94 11.6 LabCorp 94 11.6.1 LabCorp Company Details 95 11.6.2 LabCorp Business Overview 95 11.6.3 LabCorp Liver Disease Diagnostics Introduction 96 11.6.4 LabCorp Revenue in Liver Disease Diagnostics Business (2018-2023) 96 11.6.5 LabCorp Recent Development 97 11.7 Fujifilm Corporation 98 11.7.1 Fujifilm Corporation Company Details 98 11.7.2 Fujifilm Corporation Business Overview 98 11.7.3 Fujifilm Corporation Liver Disease Diagnostics Introduction 99 11.7.4 Fujifilm Corporation Revenue in Liver Disease Diagnostics Business (2018-2023) 100 11.8 Siemens Healthineers 101 11.8.1 Siemens Healthineers Company Details 101 11.8.2 Siemens Healthineers Business Overview 102 11.8.3 Siemens Healthineers Liver Disease Diagnostics Introduction 102 11.8.4 Siemens Healthineers Revenue in Liver Disease Diagnostics Business (2018-2023) 104 11.9 BD 104 11.9.1 BD Company Details 105 11.9.2 BD Business Overview 105 11.9.3 BD Liver Disease Diagnostics Introduction 106 11.9.4 BD Revenue in Liver Disease Diagnostics Business (2018-2023) 106 11.10 Cook Medical 107 11.10.1 Cook Medical Company Details 107 11.10.2 Cook Medical Business Overview 108 11.10.3 Cook Medical Liver Disease Diagnostics Introduction 108 11.10.4 Cook Medical Revenue in Liver Disease Diagnostics Business (2018-2023) 110 11.11 GE Healthcare 110 11.11.1 GE Healthcare Company Details 111 11.11.2 GE Healthcare Business Overview 111 11.11.3 GE Healthcare Liver Disease Diagnostics Introduction 112 11.11.4 GE Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023) 113 11.12 Philips Healthcare 113 11.12.1 Philips Healthcare Company Details 114 11.12.2 Philips Healthcare Business Overview 114 11.12.3 Philips Healthcare Liver Disease Diagnostics Introduction 115 11.12.4 Philips Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023) 115 11.12.5 Philips Healthcare Recent Development 116 11.13 Canon Medical Systems 116 11.13.1 Canon Medical Systems Company Details 117 11.13.2 Canon Medical Systems Business Overview 117 11.13.3 Canon Medical Systems Liver Disease Diagnostics Introduction 117 11.13.4 Canon Medical Systems Revenue in Liver Disease Diagnostics Business (2018-2023) 118 11.13.5 Canon Medical Systems Recent Development 119 11.14 Qiagen 119 11.14.1 Qiagen Company Details 120 11.14.2 Qiagen Business Overview 120 11.14.3 Qiagen Liver Disease Diagnostics Introduction 121 11.14.4 Qiagen Revenue in Liver Disease Diagnostics Business (2018-2023) 122 12 Analyst's Viewpoints/Conclusions 123 13 Appendix 125 13.1 Research Methodology 125 13.1.1 Methodology/Research Approach 125 13.1.2 Data Source 128 13.2 Author Details 131 13.3 Disclaimer 133
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート本レポートと同じKEY WORD(diagnostics)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|